Jiangxi Fushine Pharmaceutical Co. Ltd. A | Ownership
Companies that own Jiangxi Fushine Pharmaceutical Co. Ltd. A
Yunnan International Trust Co., Ltd.
2,900,148
2.36%
-4,934,602
0.28%
06/30/2017
Qian Hai Life Insurance Co., Ltd.
1,399,752
1.13%
1,399,752
0.07%
06/30/2017
Hwabao Trust Co., Ltd. (Investment Portfolio)
586,000
0.48%
-261,852
0.11%
06/30/2017
China Life Asset Management Co., Ltd.
540,000
0.44%
0
0.02%
06/30/2017
Tian Hong Asset Management Co., Ltd.
249,816
0.2%
-131,458
0.04%
12/31/2017
Truvalue Asset Management Co. Ltd.
86,108
0.07%
72,508
0.02%
12/31/2017
GF Fund Management Co., Ltd.
68,634
0.06%
9,834
0%
12/31/2017
CITIC-Prudential Fund Management Co., Ltd.
5,000
0%
0
0%
12/31/2017
CICC Fund Management Ltd.
3,200
0%
3,200
0.01%
12/31/2017
China Southern Asset Management Co., Ltd.
2,600
0%
-200
0%
12/31/2017
| Address |
Junction of Yushan & Liyang
Jingdezhen Jiangxi 333000
China
|
|
Employees
|
- |
| Website |
http://www.fushine.cn |
| Updated |
07/08/2019 |
| Jiangxi Fushine Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of active pharmaceutical ingredient (API) and pharmaceutical intermediates. It focuses on penicillin and its API and intermediates, and carbapenem and its API and intermediates. The company was founded in December 2002 and is headquartered in Jingdezhen, China. |
